Invention Grant
- Patent Title: Oral vaccine for Borrelia
- Patent Title (中): 疏螺旋体口服疫苗
-
Application No.: US11631090Application Date: 2005-06-30
-
Publication No.: US08821893B2Publication Date: 2014-09-02
- Inventor: Raymond J. Dattwyler , Maria Gomes-Solecki
- Applicant: Raymond J. Dattwyler , Maria Gomes-Solecki
- Applicant Address: US NY East Setauket
- Assignee: Bio Peptides, Corp.
- Current Assignee: Bio Peptides, Corp.
- Current Assignee Address: US NY East Setauket
- Agency: Medlen & Carroll, LLP
- International Application: PCT/US2005/023106 WO 20050630
- International Announcement: WO2006/014292 WO 20060209
- Main IPC: A61K39/02
- IPC: A61K39/02 ; C12N1/21
Abstract:
The present invention relates to vaccines for control of Borrelia infections in animal and human populations. In particular, the present invention provides compositions and methods comprising recombinant bacteria engineered to express one or more Borrelia burgdorferi antigens for use as Lyme disease vaccines. In some embodiments, the recombinant bacteria are freeze-dried.
Public/Granted literature
- US20090297560A1 Oral vaccine for Borrelia Public/Granted day:2009-12-03
Information query
